Gabapentin for chronic pelvic pain in women (GaPP2):a multicentre, randomised, double-blind, placebo-controlled trial

Autor: Andrew W Horne, Katy Vincent, Catherine A Hewitt, Lee J Middleton, Magda Koscielniak, Wojciech Szubert, Ann M Doust, Jane P Daniels, Suraiya Abdi, Santanu Acharya, Shamma Al-Inizi, Elizabeth Ball, Andrew Baranowski, Nadia Bhal, Kalsang Bhatia, Siladitya Bhattacharya, Judy V. Birch, Tyrone Carpenter, Tony Chalhoub, Ying C. Cheong, T. Justin Clark, Roman Cregg, Tunde D. Dada, Dib Datta, Radwan Faraj, Max G. Feltham, Pratima Gupta, Dharani Hapangama, Chris Hardwick, Jon Hughes, Pinky Khatri, Geeta Kumar, Lisa J. Leighton, Kingshuk Majumder, Gary J. MacFarlane, Alex Mortimer, Smita Odedra, Bruce Ramsay, Amer Raza, William Rea, Somendra Roy, Afia Sajid, Lucky Saraswat, Ahmar Shah, Jambulingam Sivasamy, Rashmi Srivastava, Clive Stubbs, Ajay Swaminathan, Premila Thampi, Omar Thanoon, Tony Thomas, Irene Tracey, Martyn Underwood, Clare Willocks, Amanda C de C. Williams, Simon Wood, Krina Zondervan

Publikováno v: Horne, A W, Vincent, K, Hewitt, C A, Middleton, L J, Koscielniak, M, Szubert, W & Doust, A M & Daniels, J P 2020, ' Gabapentin for chronic pelvic pain in women (GaPP2) : a multicentre, randomised, double-blind, placebo-controlled trial ', The Lancet, vol. 396, no. 10255, pp. 909-917 . https://doi.org/10.1016/S0140-6736(20)31693-7
Lancet (London, England)
Horne, A W, Vincent, K, Hewitt, C A, Middleton, L J, Koscielniak, M, Szubert, W, Doust, A M, Daniels, J P, Abdi, S, Acharya, S, Al-inizi, S, Ball, E, Baranowski, A, Bhal, N, Bhatia, K, Bhattacharya, S, Birch, J V, Carpenter, T, Chalhoub, T, Cheong, Y C, Clark, T J, Cregg, R, Dada, T D, Datta, D, Faraj, R, Feltham, M G, Gupta, P, Hapangama, D, Hardwick, C, Hughes, J, Khatri, P, Kumar, G, Leighton, L J, Majumder, K, Macfarlane, G J, Mortimer, A, Odedra, S, Ramsay, B, Raza, A, Rea, W, Roy, S, Sajid, A, Saraswat, L, Shah, A, Sivasamy, J, Srivastava, R, Stubbs, C, Swaminathan, A, Thampi, P & Thanoon, O 2020, ' Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial ', The Lancet, vol. 396, no. 10255, pp. 909-917 . https://doi.org/10.1016/S0140-6736(20)31693-7

© 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Background: Chronic pelvic pain affects 2–24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49677b67c9c6bbfa393d304853306cdd
https://hdl.handle.net/20.500.11820/2deb1cb7-3cd5-4fad-a3d9-77b7d6d67b4e